These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10634520)
1. Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice. Arndt D; Zeisig R; Fichtner I; Teppke AD; Fahr A Breast Cancer Res Treat; 1999 Nov; 58(1):71-80. PubMed ID: 10634520 [TBL] [Abstract][Full Text] [Related]
2. Antineoplastic activity of sterically stabilized alkylphosphocholine liposomes in human breast carcinomas. Arndt D; Zeisig R; Eue I; Sternberg B; Fichtner I Breast Cancer Res Treat; 1997 May; 43(3):237-46. PubMed ID: 9150903 [TBL] [Abstract][Full Text] [Related]
3. Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes. Fichtner I; Zeisig R; Naundorf H; Jungmann S; Arndt D; Asongwe G; Double JA; Bibby MC Breast Cancer Res Treat; 1994; 32(3):269-79. PubMed ID: 7865855 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine. Kaufmann-Kolle P; Drevs J; Berger MR; Kötting J; Marschner N; Unger C; Eibl H Cancer Chemother Pharmacol; 1994; 34(5):393-8. PubMed ID: 8070005 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: Participation of activated macrophages in the antitumor mechanism. Eue I Int J Cancer; 2001 May; 92(3):426-33. PubMed ID: 11291082 [TBL] [Abstract][Full Text] [Related]
6. Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine)-liposomes and influence of this modification on macrophage activation. Zeisig R; Eue I; Kosch M; Fichtner I; Arndt D Biochim Biophys Acta; 1996 Sep; 1283(2):177-84. PubMed ID: 8809097 [TBL] [Abstract][Full Text] [Related]
7. Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma. Teymouri M; Farzaneh H; Badiee A; Golmohammadzadeh S; Sadri K; Jaafari MR Eur J Pharm Sci; 2015 Dec; 80():66-73. PubMed ID: 26299343 [TBL] [Abstract][Full Text] [Related]
8. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine. Kaufmann-Kolle P; Berger MR; Unger C; Eibl H Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143 [No Abstract] [Full Text] [Related]
9. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity. Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations. Zeisig R; Fichtner I; Arndt D; Jungmann S Anticancer Drugs; 1991 Aug; 2(4):411-7. PubMed ID: 1797199 [TBL] [Abstract][Full Text] [Related]
11. Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro. Zeisig R; Rudolf M; Eue I; Arndt D J Cancer Res Clin Oncol; 1995; 121(2):69-75. PubMed ID: 7883777 [TBL] [Abstract][Full Text] [Related]
12. Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin. Krishna R; St-Louis M; Mayer LD Int J Cancer; 2000 Jan; 85(1):131-41. PubMed ID: 10585596 [TBL] [Abstract][Full Text] [Related]
13. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Zeisig R; Shimada K; Hirota S; Arndt D Biochim Biophys Acta; 1996 Dec; 1285(2):237-45. PubMed ID: 8972708 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacodynamics, pharmacokinetics and tissue distribution of liposomal mitoxantrone hydrochloride]. Wang CX; Li CL; Zhao X; Yang HY; Wei N; Li YH; Zhang L; Zhang L Yao Xue Xue Bao; 2010 Dec; 45(12):1565-9. PubMed ID: 21351498 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465 [TBL] [Abstract][Full Text] [Related]
16. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Charrois GJ; Allen TM Biochim Biophys Acta; 2004 May; 1663(1-2):167-77. PubMed ID: 15157619 [TBL] [Abstract][Full Text] [Related]
17. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130 [TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534 [TBL] [Abstract][Full Text] [Related]
19. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. Krishna R; Webb MS; St Onge G; Mayer LD J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822 [TBL] [Abstract][Full Text] [Related]
20. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]